SCHEMBL23370552

SCHEMBL23370552

CC(C)c1cnc(-c2ccccc2)nc1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.50
MEN1 O00255 4/20 0.50
LMNA P02545 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
ALDH1A1 P00352 3/20 0.47
MAPT P10636 2/20 0.47
MAPK1 P28482 1/20 0.47
ATM Q13315 1/20 0.47
ADORA3 P0DMS8 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
ADK P55263 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM4E B2RXH2 1/20 0.42
RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1913772 0.86 KMT2A (0.48) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL11811397 0.86 KMT2A (0.51) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
Bromide SCHEMBL11811175 0.84 KMT2A (0.47) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL12009458 0.81 SMN1; SMN2 (0.45) KMT2ALMNASMN1; SMN2ALDH1A1MAPT
SCHEMBL23370554 0.81 KDM4E (0.42) KMT2AMEN1LMNASMN1; SMN2MAPT
SCHEMBL13150859 0.81 NPC1 (0.45) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL21179360 0.80 LMNA (0.47) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL21177243 0.80 SMN1; SMN2 (0.44) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL10205907 0.77 KMT2A (0.53) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL24703781 0.76 NPC1 (0.41) KMT2AMEN1LMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210151683-A1 LIGHT-EMITTING ELEMENT, AND DISPLAY, ILLUMINATOR, AND SENSOR EACH INCLUDING SAME TORAY INDUSTRIES, INC. (JP) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210151683-A1 LIGHT-EMITTING ELEMENT, AND DISPLAY, ILLUMINATOR, AND SENSOR EACH INCLUDING SAME CBR3, INTS9, CBR1 KMT2A 1843/4885MEN1 4372/4885LMNA 1094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.